The Philadelphia Inquirer featured research by Mireille Jacobson of the USC Leonard Davis School and USC Schaeffer Center on whether recorded shortages of certain chemotherapy drugs impacted patient care. Jacobson found that although some of the chemotherapy drugs most frequently used Medicare patients had a shortage listed by the Food and Drug Administration, there was no significant impact on patient care.
